Logotype for Vetoquinol SA

Vetoquinol (VETO) Q3 2026 TU earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Vetoquinol SA

Q3 2026 TU earnings summary

28 Oct, 2026

Executive summary

  • Q3 sales reached €139.7m, up 10.4% reported and 9.6% at constant exchange rates, supported by Essentials growth and a favorable Q3 2025 base effect.

  • 9M sales totaled €399.0m, up 3.9% reported and 5.4% at constant exchange rates; excluding product-line simplification, constant-currency growth was 6.6%.

Financial highlights

  • Q1 sales were €125.0m, down 4.3% reported and 0.3% at constant exchange rates; Q2 was €134.3m, up 5.7% and 7.2%, respectively.

  • Q3 sales were €139.7m, up 10.4% reported and 9.6% at constant exchange rates; favorable currency impact was €1m from the U.S. and Americas excluding the U.S.

  • 9M reported sales growth was affected by a negative €6.1m currency impact and a €3.7m impact from product-line simplification.

Outlook and guidance

  • FY2026 annual sales release scheduled for January 14, 2027, after market close.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Vetoquinol